Verition Fund Management LLC Uni Qure N.V. Transaction History
Verition Fund Management LLC
- $13 Billion
- Q1 2024
A detailed history of Verition Fund Management LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Verition Fund Management LLC holds 310,567 shares of QURE stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
310,567
Previous 303,435
2.35%
Holding current value
$1.39 Million
Previous $2.05 Million
21.42%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding QURE
# of Institutions
148Shares Held
34.1MCall Options Held
1.07MPut Options Held
603K-
Vestal Point Capital, LP New York, NY4.73MShares$21.2 Million2.03% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.09MShares$13.8 Million1.03% of portfolio
-
683 Capital Management, LLC New York, NY1.98MShares$8.85 Million0.88% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$8.34 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.52MShares$6.8 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $209M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...